Nurix Therapeutics Inc (NAS:NRIX)
$ 15.4 -0.5 (-3.14%) Market Cap: 940.44 Mil Enterprise Value: 756.14 Mil PE Ratio: 0 PB Ratio: 4.49 GF Score: 67/100

Nurix Therapeutics Inc to Announce Strategic Collaboration with Seagen Transcript

Sep 07, 2023 / 12:30PM GMT
Release Date Price: $8.98 (+8.32%)
Operator

Hello, and welcome to the Nurix-Seagen collaboration conference call. Participants are in a listen-only mode. After the prepared remarks, there will be a Q&A session. (Operator Instructions). I would now like to turn it over to the host of today's call, Arthur Sands, President and CEO of Nurix. Arthur?

Arthur Sands
Nurix Therapeutics, Inc. - President, CEO, and Director

Thank you, Liz, and welcome to today's call announcing a very exciting and innovative collaboration between Nurix and Seagen. I'm joined on the call today by Gwenn Hansen, Nurix's Chief Scientific Officer, who will provide the scientific rationale for the collaboration; and Hans van Houte, Nurix's Chief Financial Officer; and Jason Kantor, Nurix's EVP of Finance and Business Strategy, who will be discussing the financial and business terms of the collaboration. Turning to our risk factor slide, slide 2. Before I continue, I would like to remind everyone that we will be making certain forward-looking statements, and I refer you to our most recent filings with the SEC for a full list of our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot